Skip to main content
Figure 4 | BMC Veterinary Research

Figure 4

From: Progesterone receptor isoform A may regulate the effects of neoadjuvant aglepristone in canine mammary carcinoma

Figure 4

Proliferation index. Effect of aglepristone treatment on the percentage of Ki67-labelled cells in PR-positive treated (A), PR-negative treated (B), PR-positive control (C), PR-negative control (D), PRA-positive treated (E), PRA-negative treated (F), PRA-positive control (G), PRA-negative control (H), PRB-positive treated (I), PRB-negative treated (J), PRB-positive control (K), PRB-negative control (L) canine mammary carcinomas at day 1 and day 15. *P < 0.05.

Back to article page